Personalis (PSNL) Stock Highlights

5.75 | +9.32%

2024-12-21 05:55:00

Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions.

Statistics

Range Today

5.6 7.19

Volume Today 8.03M

Range 1 Year

1.12 7.2

Volume 1 Year 186.9M

Range 3 Year

0.89 15.28

Volume 3 Year 406.97M

Range 10 Year

0.89 53.46

Volume 10 Year 755.73M

Highlights

Market Capitalization 321.45M (small)

Floating Shares 28.72M

Current Price 5.75

Price To Earnings -2.43

Price To Revenue 3.2

Price To Book 1.77

Earnings Per Share -1.82

Payout Ratio 0%

Performance

Latest +9.32%

1 Month +52.93%

3 Months -4.17%

6 Months +352.76%

1 Year +278.29%

3 Years -58.93%

5 Years -41.92%

10 Years -75.64%

Benchmarks

Market Capitalization

46 / 58

Gross Profits

47 / 52

Total Revenue

40 / 57

Total Rank

55 / 58

Free Cashflow

50 / 56

Performance 5 years

36 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.